{
  "docId": "019de516-de84-709f-9864-0c2e708269aa",
  "docSlug": "d2a0e3b4a50bc196c7afb3f2c93e5906",
  "documentTitle": "Bausch+Lomb | Results Presentation Deck | 38 slides",
  "authorId": "bausch-lomb",
  "authorName": "Bausch + Lomb",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 6,
  "pageCount": 38,
  "prevPage": 5,
  "nextPage": 7,
  "slideType": "revenue_buildup",
  "function": "decompose_segments",
  "density": "overcrowded",
  "nDataPoints": 14,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 0.9,
  "imagePath": null,
  "slideHref": "/slides/019de516-de84-709f-9864-0c2e708269aa/6",
  "deckHref": "/decks/019de516-de84-709f-9864-0c2e708269aa",
  "deckJsonHref": "/decks/019de516-de84-709f-9864-0c2e708269aa.json",
  "deckAnchorHref": "/decks/019de516-de84-709f-9864-0c2e708269aa#slide-6",
  "components": [
    {
      "bbox": {
        "h": 0.25,
        "w": 0.25,
        "x": 0.075,
        "y": 0.41
      },
      "kind": "chart",
      "text": "$1,007M 3Q23 Revenue\nPharma 17%\nSurgical 18%\nVision Care 65%",
      "attrs": {},
      "subkind": "donut",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6615732e-bf2d-4875-8ea3-52890d3f749a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.099,
        "x": 0.04,
        "y": 0.94
      },
      "kind": "image",
      "text": "BAUSCH+LOMB",
      "attrs": {},
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4f431c92-64fe-4d9d-8c22-06ce8055c5dd",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.14,
        "w": 0.16,
        "x": 0.37,
        "y": 0.26
      },
      "kind": "image",
      "text": null,
      "attrs": {},
      "subkind": "photo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0f025cb7-82b4-4138-9d7a-c58386f74f6e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.14,
        "w": 0.16,
        "x": 0.57,
        "y": 0.26
      },
      "kind": "image",
      "text": null,
      "attrs": {},
      "subkind": "photo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "14fe01ea-866a-4555-aa72-99509d6b4a75",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.14,
        "w": 0.16,
        "x": 0.77,
        "y": 0.26
      },
      "kind": "image",
      "text": null,
      "attrs": {},
      "subkind": "photo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d5f576fe-c7a4-4aba-8531-f75fd4cc2c1b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.096,
        "w": 0.25,
        "x": 0.075,
        "y": 0.218
      },
      "kind": "list",
      "text": "3Q23 vs. 3Q22\n+7% Revenue Growth Reported\n+8% Revenue Growth CC1,3",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0aefb60f-e86d-478e-ae4f-53d689555571",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.63,
        "w": 0.175,
        "x": 0.764,
        "y": 0.218
      },
      "kind": "list",
      "text": "Pharmaceuticals2\n$174M\n+1%\nStrong early Miebo launch, closed Xiidra acquisition\nGrowth in Vyzulta® and Intl. Pharma, offset by supply impact on mature brands",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6925258d-430c-4774-bc36-be6f9d20d95f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.63,
        "w": 0.175,
        "x": 0.364,
        "y": 0.218
      },
      "kind": "list",
      "text": "Vision Care2\n$648M\n+11%\nGrowth momentum in Lumify®, Eye Vitamins, Daily SiHy, Artelac®\nImproving lens order processing at Lynchburg distribution facility",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9431263d-f43d-4dd0-8750-755dc553ce47",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.63,
        "w": 0.175,
        "x": 0.564,
        "y": 0.218
      },
      "kind": "list",
      "text": "Surgical\n$185M\n+6%\nContinuing to transition portfolio to premium IOLs\nDelivering consistent level of supply remains a focus area",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f733e125-1f93-4dcc-b833-75cd1e5d48ae",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.023,
        "w": 0.09,
        "x": 0.106,
        "y": 0.802
      },
      "kind": "metric",
      "text": "$187M",
      "attrs": {},
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "45a764a4-5712-4f18-a614-5b916d854184",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.045,
        "w": 0.119,
        "x": 0.205,
        "y": 0.802
      },
      "kind": "paragraph",
      "text": "3Q23 Adj. EBITDA¹\n-$14M Adj. EBITDA FX headwinds",
      "attrs": {},
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7d993b76-42b0-4623-a70e-bdba327fe88a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.769,
        "x": 0.169,
        "y": 0.909
      },
      "kind": "source-note",
      "text": "1. This is a non-GAAP measure or ratio. See Slide 1 and Appendix for further information on non-GAAP measures and ratios.\n2. Effective in the first quarter of 2023, certain products historically included in the reported results of the Pharmaceuticals segment are now included in the reported results of the Vision Care segment and certain products included in the reported results of the Vision Care segment are now included in the reported results of the Pharmaceuticals segment. Management believes these movements are necessary in order to better align these products with the groupings of similar products. The net impact of these product movements was not material to the periods presented. Prior period presentations of segment revenues have been conformed to the current segment reporting structure.\n3. Constant currency.",
      "attrs": {},
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "39ad5424-0ca0-4db1-b0b8-e380173ad006",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.746,
        "x": 0.046,
        "y": 0.085
      },
      "kind": "title",
      "text": "Solid Revenue Growth Driven by Performance in Key Franchises",
      "attrs": {},
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9d03c2b5-e3ed-4e6e-8f0c-9ffbe059036b",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 8,
      "from": 5,
      "beatId": "ce82b39c-0b5c-4e13-9155-7aacc326b119",
      "arcName": "Monroe's Motivated Sequence",
      "arcSlug": "monroes-sequence",
      "beatName": "Need",
      "beatSlug": "monroes-sequence-need",
      "evidence": "The deck highlights the company's solid revenue growth and financial results.",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [
    {
      "to": 12,
      "from": 5,
      "name": "Logic Chain",
      "slug": "01-logic-chain",
      "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis",
      "matchId": "03b15dcd-2f58-41ce-b199-e78db7aa1af4",
      "evidence": "The deck presents a logical chain of revenue growth, growth drivers, and strategic initiatives.",
      "position": 0,
      "objective": "How will Bausch + Lomb's strategic initiatives drive growth?",
      "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)",
      "confidence": 0.7,
      "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}